NO924964D0 - Tiazolidinforbindelser og fremgangsmaate til fremstilling derav - Google Patents

Tiazolidinforbindelser og fremgangsmaate til fremstilling derav

Info

Publication number
NO924964D0
NO924964D0 NO924964A NO924964A NO924964D0 NO 924964 D0 NO924964 D0 NO 924964D0 NO 924964 A NO924964 A NO 924964A NO 924964 A NO924964 A NO 924964A NO 924964 D0 NO924964 D0 NO 924964D0
Authority
NO
Norway
Prior art keywords
alkyl
hydrogen
compounds
tiazolide
procedures
Prior art date
Application number
NO924964A
Other languages
English (en)
Other versions
NO924964L (no
NO302471B1 (no
Inventor
Takao Yoshioka
Takahide Nishi
Tsutomu Kanai
Yuichi Aizawa
Kunio Wada
Takashi Fujita
Hiroyoshi Horiyoshi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO924964D0 publication Critical patent/NO924964D0/no
Publication of NO924964L publication Critical patent/NO924964L/no
Publication of NO302471B1 publication Critical patent/NO302471B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO924964A 1991-12-26 1992-12-22 Tiazolidinforbindelser og farmasöytisk preparat NO302471B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34457191 1991-12-26

Publications (3)

Publication Number Publication Date
NO924964D0 true NO924964D0 (no) 1992-12-22
NO924964L NO924964L (no) 1993-06-28
NO302471B1 NO302471B1 (no) 1998-03-09

Family

ID=18370304

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924964A NO302471B1 (no) 1991-12-26 1992-12-22 Tiazolidinforbindelser og farmasöytisk preparat

Country Status (21)

Country Link
EP (1) EP0549365B1 (no)
JP (1) JP2833949B2 (no)
CN (1) CN1032751C (no)
AT (1) ATE126221T1 (no)
AU (1) AU654223B2 (no)
CA (1) CA2086277A1 (no)
CZ (1) CZ389792A3 (no)
DE (1) DE69204041T2 (no)
DK (1) DK0549365T3 (no)
ES (1) ES2078671T3 (no)
FI (1) FI925849A (no)
GR (1) GR3017632T3 (no)
HK (1) HK196095A (no)
HU (1) HU215450B (no)
IL (1) IL104238A (no)
MX (1) MX9207595A (no)
NO (1) NO302471B1 (no)
NZ (1) NZ245612A (no)
RU (1) RU2095354C1 (no)
TW (1) TW211007B (no)
ZA (1) ZA9210021B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO302519B1 (no) * 1991-12-26 1998-03-16 Sankyo Co Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat
EP0783888A1 (en) * 1995-12-26 1997-07-16 Sankyo Company Limited Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis
US6331633B1 (en) * 1998-05-08 2001-12-18 Calyx Therapeutics Inc. Heterocyclic analogs of diphenylethylene compounds
EP1148054B1 (en) * 2000-04-21 2005-11-23 Pfizer Products Inc. Thyroid receptor ligands
US6620830B2 (en) 2000-04-21 2003-09-16 Pfizer, Inc. Thyroid receptor ligands
AU2001259130A1 (en) * 2000-04-24 2001-11-07 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6680387B2 (en) 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6768008B2 (en) 2000-04-24 2004-07-27 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
JP2003040877A (ja) * 2001-07-24 2003-02-13 Sumika Fine Chemicals Co Ltd 5−[6−(2−フルオロベンジルオキシ)−2−ナフチル]メチル−2,4−チアゾリジンジオンの製造方法及びその精製方法
AU2007227581B2 (en) 2006-03-16 2012-11-08 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease
CA2646149A1 (en) 2006-03-16 2007-09-27 Metabolic Solutions Development Company Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids
US8304441B2 (en) 2007-09-14 2012-11-06 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic diseases
CN101848901B (zh) * 2007-09-14 2012-11-21 新陈代谢解决方案开发公司 用于治疗高血压的噻唑烷二酮类似物
ES2658168T3 (es) 2009-12-15 2018-03-08 Cirius Therapeutics, Inc. Sales de tiazolidinadiona ahorradoras de PPAR para el tratamiento de enfermedades metabólicas
EP2560956B1 (en) * 2010-04-19 2016-10-26 Octeta Therapeutics, LLC Novel synthesis for thiazolidinedione compounds
JP2013525362A (ja) * 2010-04-21 2013-06-20 メタボリック ソリューションズ ディベロップメント カンパニー, エルエルシー チアゾリジンジオン類似体
WO2012021476A1 (en) 2010-08-10 2012-02-16 Metabolic Solutions Development Company, Llc Novel synthesis for thiazolidinedione compounds
CN115433144B (zh) * 2022-10-09 2023-09-19 燃点(南京)生物医药科技有限公司 一种脂肪酸酯类化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US5143930A (en) * 1990-02-07 1992-09-01 Sankyo Company, Limited Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
NO302519B1 (no) * 1991-12-26 1998-03-16 Sankyo Co Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat

Also Published As

Publication number Publication date
NO924964L (no) 1993-06-28
HU9204130D0 (en) 1993-04-28
ES2078671T3 (es) 1995-12-16
CN1074680A (zh) 1993-07-28
JPH05239041A (ja) 1993-09-17
DE69204041T2 (de) 1996-03-28
HU215450B (hu) 1999-04-28
MX9207595A (es) 1994-06-30
HUT67788A (en) 1995-04-28
AU654223B2 (en) 1994-10-27
CN1032751C (zh) 1996-09-11
NZ245612A (en) 1994-06-27
CA2086277A1 (en) 1993-06-27
HK196095A (en) 1996-01-05
NO302471B1 (no) 1998-03-09
GR3017632T3 (en) 1996-01-31
DE69204041D1 (de) 1995-09-14
EP0549365A1 (en) 1993-06-30
CZ389792A3 (en) 1994-01-19
ZA9210021B (en) 1993-07-02
TW211007B (no) 1993-08-11
AU3043192A (en) 1993-07-01
ATE126221T1 (de) 1995-08-15
JP2833949B2 (ja) 1998-12-09
FI925849A0 (fi) 1992-12-23
DK0549365T3 (da) 1995-12-18
RU2095354C1 (ru) 1997-11-10
FI925849A (fi) 1993-06-27
IL104238A (en) 1996-10-31
EP0549365B1 (en) 1995-08-09

Similar Documents

Publication Publication Date Title
NO924964D0 (no) Tiazolidinforbindelser og fremgangsmaate til fremstilling derav
NO924988L (no) Tiazolidinforbindelser som inneholder kinongrupper, og fremgangsmaate til fremstilling derav
DK0613894T3 (da) N-Heteroaryl-N'-phenylurinstofderivater, fremstilling og anvendelse deraf
SE8600413L (sv) Nytt lekemedel och sett att framstella detsamma
ES557664A0 (es) Un procedimiento para la sintesis de derivados de imidazol.
RU92016231A (ru) Тиазолидиновые соединения, способ их получения, фармацевтическая композиция и способ лечения
IL89369A0 (en) Substituted 1,2,4-triazinediones,their preparation and their use
RU92016230A (ru) Тиазолидиновые соединения, фармацевтическая композиция, способ лечения и способы получения соединений
ES2038710T3 (es) Un procedimiento de preparacion de un derivado de benzoxazina y su utilizacion.
NO890158D0 (no) Fremgangsmaate for fremstilling av hydroksialkyleringsmiddel, de oppnaadde midler og deres anvendelse.
NO914192D0 (no) 8-azabicyklo(3.2.1)oktylalkylthiazolidinon, fremgangsmaatefor fremstilling og anvendelse som medikamenter
DK272684D0 (da) Tetrahydro-beta-carbolin-derivater og fremgangsmaade til fremstilling deraf
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
ES2044883T3 (es) Procedimiento para preparar quinoxalinas sustituidas.